Associate Professor, Psychiatry, UCSD School of Medicine

Psychiatry

Dr. Ursula F. Bailer, MD

Ursula F. Bailer is an expert in the field of Psychiatry. Doctor Ursula F. Bailer, MD is also a published doctor. She has 48 paper published. The most recent paper is: [Mirtazapine in inpatient treatment of depressed patients].

Publications

Hunger Does Not Motivate Reward in Women Remitted from Anorexia Nervosa.
Does a Shared Neurobiology for Foods and Drugs of Abuse Contribute to Extremes of Food Ingestion in Anorexia and Bulimia Nervosa?
Nothing tastes as good as skinny feels: the neurobiology of anorexia nervosa.
Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and Bulimia nervosa.
Understanding the neural circuitry of appetitive regulation in Eating disorders.
Amphetamine induced dopamine release increases anxiety in individuals recovered from anorexia nervosa.
5-HT(1A) receptor binding is increased after recovery from Bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups.
Altered striatal response to reward in Bulimia nervosa after recovery.
Altered insula response to taste stimuli in individuals recovered from restricting-type anorexia nervosa.
Altered reward processing in women recovered from anorexia nervosa.
Regional cerebral blood flow after recovery from anorexia or Bulimia nervosa.
Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa.
Personality traits after recovery from Eating disorders: do subtypes differ?
Normal brain tissue volumes after long-term recovery in anorexia and Bulimia nervosa.
Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride.
Brain imaging of serotonin after recovery from anorexia and Bulimia nervosa.
Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635.
Serotonin alterations in anorexia and Bulimia nervosa: new insights from imaging studies.
Neurobiology of anorexia nervosa: clinical implications of alterations of the function of serotonin and other neuronal systems.
Neuroimaging studies in Eating disorders.
Altered 5-HT(2A) receptor binding after recovery from Bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.
Are Extremes of Consumption in Eating Disorders Related to an Altered Balance between Reward and Inhibition?
[Depressive pseudodementia].
[Diagnosis and therapy of Eating disorders].
[123I] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in Bulimia nervosa.
Comorbidity of obsessive compulsive disorder in patients with Eating disorders.
Reboxetine in the treatment of Bulimia nervosa: a report of seven cases.
Genome scan for susceptibility loci for schizophrenia.
Occurrence of mirtazapine-induced delirium in organic brain disorder.
[Osteoporosis in anorexia nervosa. New aspects of pathogenesis and therapy].
Osteopenia in anorexia nervosa: specific mechanisms of bone loss.
[Mirtazapine in inpatient treatment of depressed patients].
No association of clock gene T3111C polymorphism and affective Disorders.
Possible linkage of schizophrenia and bipolar affective disorder to chromosome 3q29; a follow-up.
A review of neuropeptide and neuroendocrine dysregulation in anorexia and Bulimia nervosa.
Milnacipran in the treatment of Bulimia nervosa: a report of 16 cases.
Genome scan for susceptibility loci for schizophrenia and bipolar disorder.
Guided self-help versus cognitive-behavioral group therapy in the treatment of Bulimia nervosa.
Neural correlates of habituation to taste stimuli in healthy women.
Relationship of a 5-HT transporter functional polymorphism to 5-HT1A receptor binding in healthy women.
Additional support for linkage of schizophrenia and bipolar disorder to chromosome 3q29.
Serotonin transporter binding after recovery from Eating disorders.
Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.
Serotonin: imaging findings in Eating disorders.
No association of the neuropeptide Y (Leu7Pro) and ghrelin gene (Arg51Gln, Leu72Met, Gln90Leu) single nucleotide polymorphisms with Eating disorders.
Major depression and avoidant personality traits in Eating disorders.
Failure to replicate influence of GRIK4 and GNB3 polymorphisms on treatment outcome in major depression.

Conditions Treated

Bulimia
Eating Disorders

Doctors Specialties

Psychiatry

Accepted Insurances

Education

Eberhard Karls University Faculty of Medicine

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. David Feifel, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Fadi J. Nicolas, MD This Doctor is OpenDoctor Recommended.
	Dr. Matthew A. Becker, MD
	Dr. Laura J. Seed, MD
	Dr. Ana M. Andia, MD This Doctor is OpenDoctor Recommended.
	Dr. Charles D. Ashbrook, MD
	Dr. Estelle T. Goldstein, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert A. Zalewski-Zaragoza, MD This Doctor is OpenDoctor Recommended.
	Dr. Peter M. Seymour, MD This Doctor is OpenDoctor Recommended.
	Dr. Diane G. Panton, MD This Doctor is OpenDoctor Recommended.
	Dr. Gabriel T. White, MD This Doctor is OpenDoctor Recommended.
	Dr. John M. Burger, MD This Doctor is OpenDoctor Recommended.
	Dr. Daniel L. Funkenstein, MD This Doctor is OpenDoctor Recommended.